Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection96

Select a period of time:

Views

Views
December 20254
January 20267
February 20260
March 20266
April 20265
May 20263
June 202614
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States19
Finland5
Netherlands4
United Kingdom3
Brazil1
Chile1
Colombia1
Ecuador1
Kenya1
Mexico1
 

Top cities views

Views
Helsinki5
Groningen4
Asunción1
Bridgewater1
Buenaventura1
Caracas1
Cuenca1
Laplace1
Morecambe1
Nairobi1